Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University
With
Emory University
Children's National Research Institute
Age
1–4
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\) confirmed diagnosis of sickle cell disease (SCD)
2\) age between 1 and 4 years (must have reached 1st but not yet 4th birthday)
3\) a prior diagnosis of ACS, defined as acute respiratory illness with a new radiodensity on CXR, and one of the following: fever (temperature \> 38.50C), decrease in oxygen saturation more than 3% from baseline, or increase in respiratory rate above baseline
2\) those receiving blood transfusions for elevated TCD or strokes
3\) presents over 2 weeks after discharge from hospital following initial ACS episode.
Participants may be on hydroxyurea and participate in this trial.
Clareo Health | Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
